Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity.
JOURNAL OF CLINICAL IMMUNOLOGY(2024)
Key words
Letermovir,CMV Prophylaxis,Hematopoietic stem cell Transplant,Pediatrics,Inborn Errors of Immunity,Pharmacokinetics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined